Sue Ann
CHASKA, MN. October 22, 1999 -- LIFECORE BIOMEDICAL, INC. (Nasdaq:LCBM) announced today that it has been informed by the U.S. Food and Drug Administration that the November 16, 1999 General and Plastic Surgery Devices Advisory Panel meeting has been postponed. Therefore, the PMA review of Lifecore’s ferric hyaluronate product, INTERGELTM Adhesion Prevention Solution, which had been scheduled for that meeting, is delayed. The FDA indicated that it is attempting to reschedule the meeting for January 2000, and would inform the Company when a revised date has been established.